Eton Pharmaceutcials
ETON
ETON
44 hedge funds and large institutions have $27.1M invested in Eton Pharmaceutcials in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
1% more capital invested
Capital invested by funds: $26.9M → $27.1M (+$135K)
63% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 16
Holders
44
Holding in Top 10
–
Calls
$167K
Puts
$4K
Top Buyers
| 1 | +$3.1M | |
| 2 | +$658K | |
| 3 | +$420K | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$362K |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$178K |
Top Sellers
| 1 | -$214K | |
| 2 | -$202K | |
| 3 | -$169K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$167K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$156K |